Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

Yovana Portillo felt stunned that she had lung cancer because she never smoked. But she hopes people realize that lung cancer ...

For cancer patients, maintaining physical fitness and muscle strength could be a powerful weapon in the fight against the deadly disease, according to a recent study.

Southwest Healthcare Temecula Valley Hospital has become the first facility in Southwest Riverside County to successfully diagnose and treat stage 1 lung cancer using a groundbreaking combination of ...

An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a ...

Angela Terry, a lung cancer patient, tells PEOPLE that Kate's "gentle eye contact" and " level of connection " left an ...

Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published today in ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.

DATROWAY ® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...